Warner Chilcott secures FDA approval for Femtrace

ISEQ, FTSE and Nasdaq-listed Warner Chilcott has secured approval from the US Food & Drug Administration (FDA) for Femtrace™ tablets for the relief of the vasomotor symptoms (eg hot flashes, flushing) of menopause.

Warner Chilcott PLC is a specialty pharmaceutical company focused on two core therapeutic areas: women’s healthcare and dermatology.